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Abstract
Background and Purpose: The inadequacy of white-light cystoscopy to detect flat bladder tumors is well rec-
ognized. Great interest exists in developing other imaging technologies to augment or supplant conventional
cystoscopy. Fibered confocal microscopy offers the promise of providing in vivo histopathologic information to
help distinguish malignant from benign bladder lesions. We report the initial use of this technology to visual-
ize tumors in the human bladder.
Materials and Methods: We performed ex vivo fibered confocal imaging of fresh radical cystectomy specimens
using the Mauna Kea Technologies Cellvizio® system. The findings were compared with results from standard
histopathology.
Results: The bladders of four patients were imaged using the fibered confocal microscope. Normal and neo-
plastic urothelium manifested differences in cellular and vascular density.
Conclusion: This study demonstrates the feasibility of using fibered confocal microscopy to detect histologic
differences between normal and neoplastic urothelium, and establishes a foundation for the use of fiber-based
confocal microscopy in clinical studies.
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Introduction
DIAGNOSTIC CYSTOSCOPY is an indispensable part of theurologist’s armamentarium to evaluate the lower uri-
nary tract. Nevertheless, conventional white-light cysto-
scopy has numerous well-recognized shortcomings, includ-
ing operator variability, uncertainty when differentiating
inflammatory from malignant lesions, and difficulty identi-
fying flat lesions, such as carcinoma in situ (CIS). Indeed,
conventional cystoscopy may fail to visualize up to one third
of tumors.1
For pathologic confirmation, suspected lesions must be
biopsied with a delay of several days to obtain the result. To
sample the remainder of the bladder, random biopsies may
be performed, but this remains controversial in part because
of the relatively low yield.2–5 Furthermore, biopsy entails an
associated risk of bleeding and perforation, and provides a
relatively small sample size.
Strong interest exists in the development of imaging tech-
nologies to augment conventional white-light cystoscopy.
Examples include fluorescence cystoscopy with hexyl
aminolevulinate (HAL), optical coherence tomography
(OCT), and autofluorescent flexible cystoscopy. Multiple
studies have shown that HAL fluorescence cystoscopy en-
ables the visualization of more tumors in the bladder urothe-
lium than can be seen by white-light cystoscopy alone.6,7
Preliminary clinical studies of OCT demonstrate that nonin-
vasive “optical sectioning” of bladder tumors may provide
cancer staging information.8–10 An initial report of autofluo-
rescent cystoscopy indicates that this technique can help dis-
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tinguish CIS from normal urothelium without the need for
an intravesical fluorescent agent.11
None of these evolving technologies, however, provides
sufficient resolution to differentiate cellular details with mo-
lecular contrast. The ability to obtain noninvasive, real-time,
in vivo urinary tract histopathologic information during cys-
toscopy would prove useful for early diagnosis, surveillance,
and image-guided biopsy.
Technology
First developed in 1957, confocal microscopy is a power-
ful imaging tool that provides high resolution, dynamic, sub-
surface imaging of biological systems.12–14 In contrast to con-
ventional fluorescence microscopy, confocal microscopy
images are not significantly contaminated by light scattered
from other focal planes, thereby resulting in the ability to op-
tically section tissues, improved localization of signals, and
enhanced contrast.
In conventional confocal microscopy, a low-powered laser
is focused onto a single point of the specimen, and the mi-
croscope then refocuses the emitted light from the specimen.
Any out-of-focus light is removed from the image by pass-
ing through a pinhole, so only a thin optical section of the
specimen is formed.15 The illumination and detection sys-
tems are in the same focal plane and are termed confocal.16
Detection of only the light within the focal plane greatly
improves image quality and allows for visualization of sig-
nals originating from greater tissue depths. Given the large
size of conventional confocal microscopes, this approach has
been largely restricted to research, rather than clinical, ap-
plications.
Recently, new instrument designs and advances in in-
strument miniaturization17,18 have made possible the devel-
opment of flexible, fiberoptic confocal microscopes that can
be passed through the working channel of standard endo-
scopes. This enables in vivo microscopy and is referred to 
as “confocal endomicroscopy” or “fibered confocal mi-
croscopy.”
Pilot clinical studies in gastrointestinal endoscopy19–29 and
bronchoscopy30 have demonstrated excellent histologic res-
olution, producing images that resemble standard analyses
via histopathology. In addition, a single in vivo study of
fibered confocal microscopy in rat bladders has been re-
ported.31
Contrast in confocal microscopy is generated through the
use of fluorescent dyes and markers. In clinical studies, this
has largely been provided by the dyes fluorescein19,32,33 and
indocyanin green.34
To our knowledge, application of in vivo confocal mi-
croscopy in the human urinary tract has not been previously
demonstrated. We hypothesized that fibered confocal mi-
croscopy would be an adjunct to conventional white-light
cystoscopy, providing images of normal and pathologic
urothelium with cellular resolution that would improve the
accuracy of cystoscopy.
We report a study of fresh cystectomy specimens with bi-
opsy proven bladder cancer using fibered confocal mi-
croscopy. The primary objectives of this study were to prove
the feasibility of the technology and to document the pres-
ence of any morphologic differences between normal and
cancerous bladder mucosa using a generalized stain and a
confocal microscope.
Materials and Methods
The research protocol was approved by the Stanford Uni-
versity Medical Center and Veterans Affairs Palo Alto Health
Care System Institutional Review Board. Informed consent
was obtained from patients with biopsy proven bladder can-
cer who were deemed suitable candidates for radical cys-
tectomy. Immediately after cystectomy, the bladder speci-
mens were brought to our laboratory for evaluation with the
Cellvizio® fibered confocal microscope (Mauna Kea Tech-
nologies, Paris, France). To obtain optical contrast, 0.05% flu-
orescein sodium (Sigma-Aldrich, St. Louis, MO) was applied
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FIG. 1. Fibered confocal microscope, composed of a Con-
focal Miniprobe™ attached to the Laser Scanning Unit. (Im-











































































































































































































































































































































































topically to the bladder mucosa, either by directly spraying
it over the regions of interest after opening the bladder or
by instilling 200-300 mL using a Foley catheter into the in-
tact bladder. After instillation, fluorescein was left in contact
with the tissue for 5 minutes, followed by rinsing or irriga-
tion with phosphate buffered saline.
The Cellvizio fibered confocal microscope is composed of
a 2.6-mm diameter Confocal Miniprobe™ attached to the
Laser Scanning Unit (Fig. 1). Images were acquired at a rate
of 12 frames per second through direct contact of the urothe-
lium with the probe tip (Fig. 2A). The probes produce images
60 m in depth, with a lateral resolution down to 1 m, and
a field of view of 240 m in diameter. Both normal and ab-
normal appearing areas of the bladder mucosa were imaged.
The specimens were then sent for standard pathologic as-
sessment with hematoxylin and eosin (H&E) staining. Image
processing was performed using the proprietary software
from Mauna Kea Technologies. Confocal images of normal
and abnormal areas of bladder mucosa were compared with
the H&E sections of the same tissues.
Results
Four patients were recruited for the study. On final patho-
logic evaluation, two specimens had high-grade invasive
transitional cell carcinoma (TCC), one had high-grade inva-
sive primary bladder adenocarcinoma, and one had multi-
focal CIS. Instillation of fluorescein through the Foley cath-
eter yielded images of better quality than topically applied
fluorescein alone. We noted microarchitectural differences
between normal-appearing and tumor-bearing areas with re-
spect to cellular density and vascular density.
Figures 2B–E show representative images from the patient
with multifocal CIS, comparing a grossly normal area at the
dome with a suspicious appearing erythematous patch near
the trigone. In areas that appeared grossly normal, sheets of
uniform cellular structures with uneven uptake of fluores-
cein were observed (Fig. 2B). These likely correspond to the
intermediate cells seen in the H&E staining (Fig. 2C). In con-
trast, a dense arborized network in a background of irregu-
lar cellular structures was seen at the region of the erythe-
matous patch (Fig. 2D). This region was confirmed to be CIS,
characterized by denuded mucosa, local hemorrhage, and
lymphocytic infiltrate (Fig. 2E). These arborized structures,
which we speculate represent increased vascular density,
were seen consistently in the suspicious regions of the blad-
ders with TCC.
Discussion
We report the first application of fibered confocal mi-
croscopy in the human urinary tract using a Confocal
Miniprobe from Mauna Kea Technologies. Using fresh sur-
gical specimens from patients with bladder cancer and top-
ical fluorescein as contrast, we observed morphologic dif-
ferences between normal bladder mucosa and cancerous
areas that were confirmed using standard H&E sectioning.
The data were obtained rapidly from relatively intact tissues,
offering the prospect of using this microscope in the clinic.
The possibility of acquiring real-time histopathologic in-
formation of urinary tract pathology (ie, “optical biopsy”), if
realized, would represent an important advance in en-
dourology. While bladder biopsy only obtains a static, his-
tologic snapshot of small pieces of tissue, fibered confocal
microscopy offers a dynamic survey of selected areas of the
urothelium.
While promising, our pilot ex vivo study has several limita-
tions, particularly the small sample size and the nonquantita-
tive, descriptive nature of our image interpretation. Our pre-
liminary experience with fibered confocal microscopy
precludes us from making conclusive statements regarding the
observed confocal images beyond empiric pattern recognition.
These observations argue that contrast agents with molec-
ular specificity would be detectable using this microscope,
and such agents may have a significant impact on detection
and diagnosis. Such studies have been reported using pep-
tide probes in the colon.35 In addition, the recently devascu-
larized bladder specimens, resulting in varying degrees of cell
death, may explain the inconsistent staining of fluorescein.
Comparison with standard histopathologic analysis is
limited because the fibered confocal microscope produces
images of horizontal planes, parallel to the surface of the
bladder, while vertical sections are displayed in routine
histopathologic analysis.
Based on our ex vivo experience, we are initiating an in
vivo study to assess bladder tumors using fibered confocal
microscopy with fluorescein as a contrast agent. By imaging
selected normal or abnormal-appearing areas of the bladder
before surgical biopsy, this technology may improve the rate
of positive findings in “random” bladder biopsy and reduce
unnecessary biopsies.
At this time, the Cellvizio probe fits within the working
channel of a standard resectoscope. Further advances in
miniaturization, however, may enable future compatibility
with flexible cystoscopes for office use.
Conclusion
While the depth of penetration of fibered confocal mi-
croscopy will likely remain insufficient to provide informa-
tion about muscle invasiveness, and the requirement for di-
rect tissue contact with the probe makes imaging of the entire
urothelium impractical, we anticipate that confocal endomi-
croscopy may complement other novel imaging modalities
to improve conventional white-light cystoscopy, and that ad-
ditional advances in the technology will increase its utility.
Disclosure Statement
Funding support has been provided by the Stanford Can-
cer Center Developmental Cancer Research Award. Techni-
cal support has been provided by Mauna Kea Technologies.
References
1. Zaak D, Kriegmair M, Stepp H, et al. Endoscopic detection
of transitional cell carcinoma with 5-aminolevulinic acid: Re-
sults of 1012 fluorescence endoscopies. Urology 2001;57:690–
694.
2. Swinn MJ, Walker MM, Harbin LJ, Adshead JM, Witherow
RO, Vale JA, Patel A. Biopsy of the red patch at cystoscopy:
Is it worthwhile? Eur Urol 2004;45:471–474.
3. van der Meijden A, Oosterlinck W, Brausi M, Kurth KH,
Sylvester R, de Balincourt C. Significance of bladder biopsies
in Ta,T1 bladder tumors: A report from the EORTC Genito-
Urinary Tract Cancer Cooperative Group. EORTC-GU Group
Superficial Bladder Committee. Eur Urol 1999;35:267–271.
4. May F, Treiber U, Hartung R, Schwaibold H. Significance of
random bladder biopsies in superficial bladder cancer. Eur
Urol 2003;44:47–50.
SONN ET AL.200
5. Fujimoto N, Harada S, Terado M, Sato H, Matsumoto T.
Multiple biopsies of normal-looking urothelium in patients
with superficial bladder cancer: Are they necessary? Int J
Urol 2003;10:631–635.
6. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Rite-
nour C, Nseyo U, Droller MJ. A phase III, multicenter com-
parison of hexaminolevulinate fluorescence cystoscopy and
white light cystoscopy for the detection of superficial pap-
illary lesions in patients with bladder cancer. J Urol 2007;
178:62–67.
7. Schmidbauer J, Witjes F, Schmeller N,Donat R, Susani M,
Marberger M. Improved detection of urothelial carcinoma
in situ with hexaminolevulinate fluorescence cystoscopy. J
Urol 2004;171:135–138.
8. Manyak MJ, Gladkova ND, Makari JH, et al. Evaluation of
superficial bladder transitional-cell carcinoma by optical co-
herence tomography. J Endourol 2005;19:570-574.
9. Lerner SP, Goh AC, Tresser NJ, Shen SS. Optical coherence
tomography as an adjunct to white light cystoscopy for in-
travesical real-time imaging and staging of bladder cancer.
Urology 2008;72:133–137.
10. Hermes B, Spöler F, Naami A, Bornemann J, Först M, Grosse
J, Jakse G, Knüchel R. Visualization of the basement mem-
brane zone of the bladder by optical coherence tomography:
Feasibility of noninvasive evaluation of tumor invasion.
Urology 2008;72:677–681.
11. Golijanin DJ, Singer EA, Messing EM. Management of car-
cinoma in situ of the bladder. AUA News. 2008; pp 11.
12. Minsky M. Microscopy apparatus. US. Patent 3013467.
United States. 1961.
13. Minsky M. Memoir on inventing the confocal scanning mi-
croscope. Scanning 1988;10:128–138.
14. Pawley JB. Handbook of Biological Confocal Microscopy.
New York: Springer; 2006.
15. Robinson JP. Principles of confocal microscopy. Methods
Cell Biol 2001;63:89–106.
16. Kiesslich R, Goetz M, Neurath MF. Confocal laser endomi-
croscopy for gastrointestinal diseases. Gastrointest Endosc
Clin N Am 2008;18:451–466.
17. Helmchen F. Miniaturization of fluorescence microscopes
using fibre optics. Exp Physiol 2002;87:737–745.
18. Yelin D, Rizvi I, White WM, Motz JT, Hasan T, Couma BE,
Tearney GJ. Three-dimensional miniature endoscopy. Na-
ture 2006;443:765.
19. Wang TD, Friedland S, Sahbaie P, Soetikno R, Hsiung PL,
Liu JT, Crawford JM, Contag CH. Functional imaging of
colonic mucosa with a fibered confocal microscope for real-
time in vivo pathology. Clin Gastroenterol Hepatol 2007;
5:1300–1305.
20. Becker V, von Delius S, Bajbouj M, Karagianni A, Schmid
RM, Meining A. Intravenous application of fluorescein for
confocal laser scanning microscopy: Evaluation of contrast
dynamics and image quality with increasing injection-to-
imaging time. Gastrointest Endosc 2008;68:319–323.
21. Meining A, Wallace MB. Endoscopic imaging of angiogen-
esis in vivo. Gastroenterology 2008;134:915–918.
22. Meining A, Frimberger E, Becker V, Von Delius S, Von Wey-
hern CH, Schmid RM, Prinz C. Detection of cholangio-
carcinoma in vivo using miniprobe-based confocal fluores-
cence microscopy. Clin Gastroenterol Hepatol 2008;6:1057–
1060.
23. Becker V, Vercauteren T, von Weyhern CH, Prinz C, Schmid
RM, Meining A. High-resolution miniprobe-based confocal
microscopy in combination with video mosaicing (with
video). Gastrointest Endosc 2007;66:1001–1007.
24. Meining A, Bajbouj M, Schmid RM. Confocal fluorescence
microscopy for detection of gastric angiodysplasia. En-
doscopy 2007;39(suppl 1):E145.
25. Meining A, Saur D, Bajbouj M, et al. In vivo histopathology
for detection of gastrointestinal neoplasia with a portable,
confocal miniprobe: An examiner blinded analysis. Clin Gas-
troenterol Hepatol 2007;5:1261–1267.
26. Meining A, Schwendy S, Becker V, Schmid RM, Prinz C. In
vivo histopathology of lymphocytic colitis. Gastrointest En-
dosc 2007;66:398–400.
27. Miehlke S, Morgner A, Aust D, Madisch A, Vieth M, Baret-
ton G. Combined use of narrow-band imaging magnification
endoscopy and miniprobe confocal laser microscopy in neo-
plastic Barrett’s esophagus. Endoscopy 2007;39(suppl 1):E316.
28. Morgner A, Stolte M, Miehlke S. Visualization of lym-
phoepithelial lesions in gastric mucosa-associated lymphoid
tissue-type lymphoma by miniprobe confocal laser mi-
croscopy. Clin Gastroenterol Hepatol 2007;5:e37.
29. von Delius S, Feussner H, Wilhelm D, Karagianni A, Henke
J, Schmid RM, Meining A. Transgastric in vivo histology in
the peritoneal cavity using miniprobe-based confocal fluo-
rescence microscopy in an acute porcine model. Endoscopy
2007;39:407–411.
30. Thiberville L, Moreno-Swirc S, Vercauteren T, Peltier E,
Cavé C, Bourg Heckly G. In vivo imaging of the bronchial
wall microstructure using fibered confocal fluorescence mi-
croscopy. Am J Respir Crit Care Med 2007;175:22–31.
31. D’Hallewin MA, El Khatib S, Leroux A, Bezdetnaya L,
Guillemin F. Endoscopic confocal fluorescence microscopy
of normal and tumor bearing rat bladder. J Urol 2005;174:
736–740.
32. Polglase AL, McLaren WJ, Skinner SA, Kiesslich R, Neurath
MF, Delaney PM. A fluorescence confocal endomicroscope
for in vivo microscopy of the upper- and the lower-GI tract.
Gastrointest Endosc 2005;62:686–695.
33. Kiesslich R, Gossner L, Goetz M, et al. In vivo histology of
Barrett’s esophagus and associated neoplasia by confocal
laser endomicroscopy. Clin Gastroenterol Hepatol 2006;4:
979–987.
34. Mueller AJ, Bartsch DU, Folberg R, et al. Imaging the mi-
crovasculature of choroidal melanomas with confocal indo-
cyanine green scanning laser ophthalmoscopy. Arch Oph-
thalmol 1998;116:31–39.
35. Hsiung PL, Hardy J, Friedland S, et al. Detection of colonic
dysplasia in vivo using a targeted heptapeptide and confo-
cal microendoscopy. Nat Med 2008;14:454–458.
Address reprint requests to:
Joseph C. Liao, M.D.
Department of Urology
Stanford University School of Medicine
300 Pasteur Drive, S-287
Stanford, CA 94305-5118
E-mail: jliao@stanford.edu
BLADDER FIBERED CONFOCAL MICROSCOPY 201
Abbreviations Used
CIS  carcinoma in situ
HAL  hexyl aminolevulinate
H&E  hematoxylin and eosin
OCT  optical coherence tomography
TCC  transitional-cell carcinoma
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